发明授权
US06726624B2 METHOD AND APPARATUS FOR DETERMINING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MEDICATION DOSAGE AND FOR MONITORING THE EFFECTS OF ADHD MEDICATION ON PEOPLE WHO HAVE ADHD USING COMPLEMENTARY TESTS
失效
用于确定缺陷性高血压疾病(ADHD)药物剂量和用于监测ADHD药物对具有ADHD的患者使用补充测试的方法和装置
- 专利标题: METHOD AND APPARATUS FOR DETERMINING ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) MEDICATION DOSAGE AND FOR MONITORING THE EFFECTS OF ADHD MEDICATION ON PEOPLE WHO HAVE ADHD USING COMPLEMENTARY TESTS
- 专利标题(中): 用于确定缺陷性高血压疾病(ADHD)药物剂量和用于监测ADHD药物对具有ADHD的患者使用补充测试的方法和装置
-
申请号: US10092284申请日: 2002-03-06
-
公开(公告)号: US06726624B2公开(公告)日: 2004-04-27
- 发明人: Richard S. Keirsbilck , Peter A. Parks , David L. Patton , Richard N. Blazey , Paige Miller
- 申请人: Richard S. Keirsbilck , Peter A. Parks , David L. Patton , Richard N. Blazey , Paige Miller
- 主分类号: A61B500
- IPC分类号: A61B500
摘要:
A method for determining the appropriate dosage of a medication to treat Attention Deficit Hyperactivity Disorder (ADHD) in an individual who has ADHD. The method comprises sampling the peripheral skin temperature of left and right like extremities of an individual during a predetermined time interval when the individual is in a sensory deprived state to provide respective left and right sampled peripheral skin temperature data; processing the sampled peripheral skin temperature data; processing the sampled peripheral skin temperature data including filtering, differentiation, and conversion to the frequency domain to derive spectral signatures whose magnitudes are indicative of the level of ADHD manifestation. The effectiveness of the medication is calculated by comparison to predetermined threshold values.
公开/授权文献
信息查询